The non-clinical contract research services and research model provider Envigo launches a new solution it says optimizes non-clinical safety assessment programs to enable first-in-human clinical trials.
Charles River is eyeing M&A opportunities in every segment of its business, fueled by global market demand and a “fundamental shift” in the pharmaceutical industry, says CEO.
Charles River will manage and provide staffing for NIAID’s vivarium and related research model operations to support biomedical research across multiple scientific disciplines.